Report #2861939

Received Sep 29, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: Age unknown
State: NY
Recovered: Unknown
Vaccinated: Sep 10, 2025
Onset: Sep 10, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
RSV	RSV (AREXVY)	GLAXOSMITHKLINE BIOLOGICALS	2	—	—

Symptoms (1)

Extra dose administered

Symptom narrative

Patient received 2 doses of Arexvy in a 1 year span; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of extra dose administered in a 83-year-old male patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis. Previously administered products included Arexvy (The 1st does was given on 21 Feb 2024). On 10-SEP-2025, the patient received the 2nd dose of Arexvy. On 10-SEP-2025, an unknown time after receiving Arexvy, the patient experienced extra dose administered (Verbatim: Patient received 2 doses of Arexvy in a 1 year span). The outcome of the extra dose administered was not applicable. Additional Information: GSK Receipt Date: 15-SEP-2025 Pharmacist called to report that an 83 years old male patient received two doses of Arexvy on a 1 year span. The 1st does was given on 21 Feb 2024. The 2nd dose was given on 10 Sep 2025.